recall
saveGlenmark Pharmaceuticals Inc., USA recall (Cls II)
community read0 votes
Carvedilol Tablets, USP, 12.5 mg, Rx only, a)500 Tablets, NDC 68462-164-05; b) 100 Tablets, NDC 68462-164-01, Manufactured for Glenmark Pharmaceuticals, NJ. — Reason: CGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit. — Status: Ongoing
view source ↗Data sources
last refreshed 45m ago
Found something off?
same company · ±60 days · 6
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Feb 12, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Feb 26, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Feb 26, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Feb 26, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Feb 26, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Feb 26, 2025
comments(0)
5-min edit window · permanent after that